Determination of the targets of a compound remains
an essential aspect in drug discovery. A complete understanding of all binding interactions is critical to recognize in advance both therapeutic effects and undesired consequences. However, the complete polypharmacology of many drugs currently in clinical development is still unknown, especially in the case of G-protein-coupled receptor (GPCR) ligands. In this work we have developed a chemoproteomic platform based on the use of chemical probe...
↧
Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and ...
↧